Clinical trial
Evaluation of the OtoBand as a Treatment to Reduce the Perceived Loudness of Tinnitus
NCT04787653 is registered in ClinicalTrials.gov with Otolith Labs as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the OtoBand as a Treatment to Reduce the Perceived Loudness of Tinnitus
- Lead sponsor
- Otolith Labs
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 5, 2021
- Completion date
- February 28, 2024
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.